ProAxsis (www.proaxsis.com) is delighted to have been featured in the latest edition of Business Eye, Northern Ireland’s premium business magazine. This article follows the company’s recent move to the Catalyst Inc facilities, in the Titanic Quarter of Belfast, and highlights the history and the future plans of the company.
The full article can be viewed via the following link: https://issuu.com/hexagondesign/docs/bizeye_aug_sept_2016/c/smqz2y9
Any queries concerning ProAxsis’ Immunoassay for measuring active neutrophil elastase, or any requests for support with measuring other active protease biomarkers using the company’s proprietary ProteaseTag® technology, can be directed to info@77.104.171.207.
ProAxsis is part of the NetScientific group and is one of the group’s core portfolio companies. The company is also supported by QUBIS, the commercialisation arm of Queens University.
Related News
ProAxsis Limited (www.proaxsis.com) is further expanding its ProteaseTag® technology platform, via a project co-funded by the UK’s innovation …
Dr David Ribeiro, CEO of ProAxsis, will be attending the 10th anniversary Biotrinity conference, taking place in London on …
ProAxsis will this week be presenting new data on its ProteaseTag® technology, at the North American Cystic Fibrosis Conference …
